β-Sitosterol ameliorates metabolic dysfunction-associated steatohepatitis by targeting the RAC1/mTOR/TFEB axis thus activating lipophagy-lysosomal pathway

Acta Pharmacologica Sinica 2026 Open access

Read full text

Authors: Yang Wang, Yi Sun, Chang-yuan Wang, Min Cao, Ru Hao, Shan Wang, Hui-jun Sun

DOI: 10.1038/s41401-025-01702-8

Cited by: 2

References: 59

Fields of Study & Subjects

Liver Disease Diagnosis and Treatment Cholesterol and Lipid Metabolism Sphingolipid Metabolism and Signaling

References 59